The task force of the Korean Society for Reproductive Immunology recommends intravenous immunoglobulin G treatment in women with reproductive failure, including recurrent pregnancy loss and/or repeated implantation failure, who show cellular immune factors such as abnormal natural killer cell levels, natural killer cell cytotoxicity, and/or type 1 T helper immunity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395546 | PMC |
http://dx.doi.org/10.5653/cerm.2017.44.1.1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!